Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: March 26, 2023

Drug Sales Trends for LEVETIRACETAM

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Payment Methods and Pharmacy Types for LEVETIRACETAM (2019)

Revenues by Pharmacy Type

Chart
Table

Pharmacy Type	Revenues
MAIL-ORDER	$894,217
INSIDE ANOTHER STORE	$38,174,817
[disabled in preview]	$16,145,601
This preview shows a limited data set Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Chart
Table

Pharmacy Type	Units
MAIL-ORDER	8,906
INSIDE ANOTHER STORE	296,081
[disabled in preview]	172,631
This preview shows a limited data set Subscribe for full access, or try a Trial

Revenues by Payment Method

Chart
Table

Payment Method	Revenues
MEDICAID	$9,648,425
MEDICARE	$29,345,963
[disabled in preview]	$16,220,247
This preview shows a limited data set Subscribe for full access, or try a Trial

Drug Sales Revenue Trends for LEVETIRACETAM

Drug Units Sold Trends for LEVETIRACETAM

Annual Sales Revenues and Units Sold for LEVETIRACETAM

These sales figures are drawn from a US national survey of drug expenditures

Subscribe to access the full database, or Try a Trial
Drug Name	Revenues (USD)	Units	Year
LEVETIRACETAM	See Plans and Pricing	See Plans and Pricing	2019
LEVETIRACETAM	See Plans and Pricing	See Plans and Pricing	2018
LEVETIRACETAM	See Plans and Pricing	See Plans and Pricing	2017
LEVETIRACETAM	See Plans and Pricing	See Plans and Pricing	2016
>Drug Name	>Revenues (USD)	>Units	>Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

McKinsey

Harvard Business School

Dow

Colorcon

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.